Smokeless Tobacco Use Clinical Trial
Official title:
A Pilot Study to Assess the Effectiveness of the Nicotine Lozenge for Smokeless Tobacco Users
The investigators are hypothesizing that by offering both self-help materials and mailed nicotine lozenges we will be able to help increase tobacco abstinence rates among ST users, as well as decrease tobacco withdrawal.
Smokeless tobacco (ST) is a known human carcinogen. Long-term ST use is known to increase the risk for oropharyngeal cancer. Most smokeless tobacco users wish to quit. Assisted-self help interventions (i.e., self-help manual, a targeted video, and two support telephone phone calls) have been shown to be superior to manual-only interventions for increasing tobacco abstinence rates. These interventions lend themselves to widespread dissemination, but abstinence rates at 6 months remains low (21%). Providing nicotine replacement therapy (NRT) to ST users receiving assisted self-help interventions could improve upon these ST abstinence rates. If found to be effective, this intervention may increase the ability to disseminate effective interventions to a population of tobacco users for whom few treatment resources currently exist. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00680615 -
An Internet-Based Smokeless Tobacco Cessation Program for Teens
|
Phase 2 | |
| Completed |
NCT00939029 -
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
|
Phase 2/Phase 3 | |
| Completed |
NCT00392379 -
Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
|
Phase 3 | |
| Completed |
NCT01067586 -
Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
|